The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $14.52 in the prior trading day, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) closed at $14.29, down -1.58%. In other words, the price has decreased by -$1.58 from its previous closing price. On the day, 1.01 million shares were traded. ACAD stock price reached its highest trading level at $14.68 during the session, while it also had its lowest trading level at $14.15.
Ratios:
Our goal is to gain a better understanding of ACAD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 29.45. For the most recent quarter (mrq), Quick Ratio is recorded 1.95 and its Current Ratio is at 2.16. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On August 07, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $28 to $20.
On June 27, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $31.BMO Capital Markets initiated its Outperform rating on June 27, 2024, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 ’24 when Schneyer Mark C. sold 9,733 shares for $15.28 per share. The transaction valued at 148,720 led to the insider holds 43,735 shares of the business.
Teehan Brendan sold 9,534 shares of ACAD for $145,680 on Aug 19 ’24. The EVP, COO, HEAD OF COMMERCIAL now owns 52,177 shares after completing the transaction at $15.28 per share. On Aug 19 ’24, another insider, DAVIS STEPHEN, who serves as the CEO of the company, sold 31,747 shares for $15.28 each. As a result, the insider received 485,094 and left with 186,555 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACAD now has a Market Capitalization of 2370368000 and an Enterprise Value of 1927082752. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 80.06, and their Forward P/E ratio for the next fiscal year is 17.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.66 while its Price-to-Book (P/B) ratio in mrq is 4.59. Its current Enterprise Value per Revenue stands at 2.164 whereas that against EBITDA is 56.226.
Stock Price History:
Over the past 52 weeks, ACAD has reached a high of $32.59, while it has fallen to a 52-week low of $14.31. The 50-Day Moving Average of the stock is -8.21%, while the 200-Day Moving Average is calculated to be -22.70%.
Shares Statistics:
The stock has traded on average 1.59M shares per day over the past 3-months and 1106850 shares per day over the last 10 days, according to various share statistics. A total of 164.65M shares are outstanding, with a floating share count of 164.61M. Insiders hold about 0.76% of the company’s shares, while institutions hold 97.84% stake in the company. Shares short for ACAD as of 1727654400 were 7979555 with a Short Ratio of 5.02, compared to 1724976000 on 10266001. Therefore, it implies a Short% of Shares Outstanding of 7979555 and a Short% of Float of 6.5.
